InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ordonez Claudia, Directeur Médical. Officer active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. History available since 11 May 2021. The latest transaction was filed on 11 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
1,000 shares@ US$0.4825.0% of flowCommon StockSEC:0001209191-21-040648
1,000 shares@ US$0.480.0001% mcap25.0% of flowCommon StockSEC:0001209191-21-040648:0
1,000 shares@ US$0.480.0001% mcap25.0% of flowCommon StockSEC:0001209191-21-032361:0
1,000 shares@ US$0.4825.0% of flowCommon StockSEC:0001209191-21-032361
4 of 4 declarations
About Ordonez Claudia
Claudia Ordonez is Chief Medical Officer at Keros Therapeutics, Inc., a biopharmaceutical company. She is responsible for medical strategies and clinical operations. Her expertise in medicine and research is essential for the development of new treatments.
